Die GCP-Verordnung dient, ebenso wie die §§ 40–42a des Arzneimittelgesetzes, der Umsetzung der europäischen GCP-Richtlinie in deutsches Recht. Current E6(R2) Addendum Step 4 version. Code. History. Date. E6(R2). Adoption by the Regulatory Members of the ICH Assembly under Step. Juli Die nach AMG und GCP-V erforderlichen Angaben und Unterlagen entnehmen Sie den beigefügten Anlagen.

Author: Fauzil Grocage
Country: Romania
Language: English (Spanish)
Genre: Literature
Published (Last): 27 December 2018
Pages: 384
PDF File Size: 15.19 Mb
ePub File Size: 8.83 Mb
ISBN: 370-2-93880-763-4
Downloads: 18195
Price: Free* [*Free Regsitration Required]
Uploader: Kajizahn

GCP inspections — which affect study sites, laboratories, sponsors and contract research organizations CRO alike — make up an important part of these regulations. A common understanding of how these regulations apply in daily life is however not always ensured. The survey, conducted with the help of 15 pharmaceutical companies within the VFA, included a total of inspections 74 inspections in Germany, from other European countries.

The survey illustrated, that inspections usually are conducted at the investigational site, and that most of the findings are well known and thus could be prevented by communicating and discussing audit results more intensely within study groups. Again, the survey illustrated, that a harmonization of inspections appears warranted.

Finally a code of practice is provided that considers these findings and delivers a basis for a successful inspection whether at the sponsor or the GCP site.

The efficiency of these measures is ensured by internal audits by the sponsor ICH E6, glossary 1. Since the interpretation of these regulations is subject to continuous refinement, it is essential for research-based pharmaceutical companies to be sure about the expectations of authorities and to be aware of the specific conduct of these GCP inspections.

The working group consists of GCP inspectors from member states and the chairman is recruited from within the EMEA-section for inspections. Attachment 1 Attachment 1 gives an overview about the European directives and international rules considering GCP inspections. The implementation of the European legislation into national German law is displayed in Attachment 2 Attachment 2. The situation in Germany is special in that there is a task sharing between the federal higher authority and local authorities within federal states.

The federal higher authority is responsible for approving clinical trials and licensing pharmaceuticals.


Attachment 3 Attachment 3 contains further helpful and publicly accessible information sources regarding GCP inspections. Of particular interest for sponsors based in Germany is the ZLG website [ 7 ], which provides a detailed and excellently rehashed overview of national and international regulations as well as links to international and national verorxnung. Ideally a continuous dialogue between authorities and sponsors regarding the correct interpretation of the regulatory basis of GCP and the resulting steps for improving quality should be established aiming at improving clinical research and patient safety in Germany.

Publicly available reports of GCP inspections are rare [ 8 ], [ 9 ], [ 10 ] and mostly from Great Britain. This reflects verlrdnung response rate of The companies reported a total of inspections 74 inspections in Germany, from other European countries.

Of note, the survey only included clinical trials performed by the pharmaceutical industry and does not reflect the situation of investigator initiated research, which might be different. Specifically we vwrordnung for the type of inspection, the responsible inspecting authority verordning.


Pre-Clinical Trial Application, pre-approval, for cause, routine and for the findings of the inspection. The frequency of sponsor inspections and inspections at the investigational site differs substantially when comparing Germany to the rest of Europe Figure 1 Fig.

Investigational site gerordnung were most frequent both in Germany and Europe.

From 73 out of reported inspections a total of findings were reported. The range of findings is displayed in Figure 2 Veroednung. In addition to these the availability and content of standard operating procedures SOP was a further finding in other European countries.

The ability to generalize is however restricted due to different internal organizations and thus the code of practice has to be adapted to vreordnung for an inspection. The following steps are necessary for the preparation, conduct and follow-up of an inspection.

In the course of the written notification of a GCP inspection a number of information regarding the company are requested. These include organizational charts, overviews of ongoing or completed studies within a particular time frame and lists of standard operating procedures.

A draft agenda may be provided. Additional documents that may be requested before the inspection verordnugn While the inspection date is usually not negotiable, the agenda may have room for discrete changes. The internal preparation for the inspection include the following: At the first day of the inspection frequently evrordnung is a common meeting with inspectors and staff of the sponsor.

During the course of this meeting the inspectors illustrate the reason for the inspection legal requirements. The company then has room for a short introduction before the final agenda is agreed upon and logistic questions answered. At the workplace of the inspector s the following material has to be provided: These and all documents that are requested during inspection should be labelled to be confidential and every single item recorded.

The inspectors will veroddnung through the documents provided and conduct a considerable number of interviews. It is also important to record the questions during the interview usually task of Quality Assurance. Documents requested verrordnung the inspectors have to be delivered as soon as possible.


The active phase of the GCP inspection ends with a discussion, at which the inspectors summarize and assess the essential results and the company has the opportunity to explain these. Again a detailed protocol is mandatory. Inspections require as much time for veorrdnung as for preparation. Berordnung information constitute an independent feedback which is verordnuhg welcome to improve the internal organization. The following steps are very important: GCP inspections — which affect study sites, laboratories, sponsors and contract research organizations CROs alike — make up an important part of the regulations laid down in these directives.

There is however room for a differential interpretation of these guidelines and guidance on how to apply these is warranted. This is particularly important in countries like Germany in which many different authorities interact and perform GCP inspections.

A close dialogue between the competent authorities and the sponsor about the interpretation of fundamental regulatory requirements with regard to GCP would improve the quality of clinical research and reduce the uncertainties when being inspected by different authorities.


It is the more surprising that key learnings from these inspections are obviously not used to improve the results of subsequent inspections; results of repeated inspections are frequently quite similar. A more intense follow-up and interchange between companies should allow to raise the awareness for the most salient points and thus increase the quality of clinical trial conduct.

The provided guidance may represent an essential step cerordnung this direction.

veeordnung This can be demonstrated by the increasing number of clinical studies in Germany and the excellent quality of its investigational sites. National Center for Biotechnology InformationU.

Journal List Ger Med Sci v. Published online Mar Author information Article notes Copyright and License information Disclaimer. Received Nov 21; Revised Mar You are free to copy, distribute and transmit the work, provided the original author and source are credited. This article has been cited by other articles in PMC.

Associated Data Supplementary Materials Attachment 1: International orders and guidelines with respect to GCP inspections. National German orders, guidelines and laws with respect to GCP inspections. Further useful sources verordnug information on GCP inspections. An identical interpretation of GCP laws and guidelines is mandatory.

Veordnung first step into this direction has been undertaken by formation of the ZLG and their publicly available procedural requirements. A guideline on how to interpret these procedural requirements is however essential.

Open in a separate window. Type of inspections in Germany in comparison to Europe without Germany [11]. Findings from site inspections from a survey of VFA companies in Germany [11]. In Germany inspections are as opposed to other European countries conducted by a variety of authorities.

Of note, recently the number of local authorities in North Rhine-Westphalia was reduced from 59 to 1 central authority for this Federal State. Most findings from these inspections are well known and could be addressed to the sites in order to avoid them in the future. Preparation In the course of the written notification of a GCP inspection a number of information regarding the company are requested.

Conduct example At the first day of the inspection verotdnung there is a common meeting with inspectors and staff of the sponsor. Follow-up Inspections require as much time for follow-up as for preparation. Notes Conflicts of interest None declared. Supplementary Material Attachment 1: International orders and guidelines with respect to GCP inspections: Click here to view.

National German orders, guidelines and laws with respect to GCP inspections: Further useful sources of information on GCP inspections: Guideline for Good Clinical Practice. Version of July including post veeordnung errata of July [Internet] London: Emea; [updated 16 March, ; cited May ].

Support Center Support Center. Please review our privacy policy.